At this point, it is premature to emphasize that a low PON1 concentration might be implicated in NAFLD/NASH pathogenesis nor can we say that NAFLD might reduce PON1 concentration. This evidence concerns the gene PON1 and metabolic dysfunction-associated steatotic liver disease.